Home > Insider Trading > Filing (0001104659-19-064171)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439222	Agios Pharmaceuticals Inc.	AGIO	Pharmaceutical Preparations (2834)	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
816284	Celgene Corp /De/	Celgene Corporation 86 Morris Avenue Summit NJ 07901	No	No	Yes	No
1577650	Celgene European Investment Co Llc	86 Morris Avenue Summit NJ 07901	No	No	Yes	No
1581774	Celgene Alpine Investment Co., Llc	86 Morris Avenue Summit X1 07901	No	No	Yes	No
1661486	Celgene Switzerland Llc	Aon House 30 Woodbourne Avenue Pembroke D0 HM 08	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-11-12	403,225	$31.00	1,777,824	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	624,575	Indirect	See footnote
Common Stock	4,010,926	Indirect	See footnote
Common Stock	708,333	Indirect	See footnote

Footnotes

Owned directly by Celgene Switzerland LLC, a wholly-owned subsidiary of Celgene Corporation ("Celgene"). Celgene and the other reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
Owned directly by Celgene European Investment Company LLC, a wholly-owned subsidiary of Celgene. Celgene and the other reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
Owned directly by Celgene Alpine Investment Co., LLC, a wholly-owned subsidiary of Celgene. Celgene and the other reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.